[Edaily Reporter Kwon Oh-seok] #GenQrix shares are showing strength in early trading. Buying interest appears to be surging following news that the company has been selected for a government-funded project worth approximately 300억 won. According to MP Doctor on the 17th, as of 9:28 a.m., GenQriX shares are trading at 2,445 won, up 6.30% from the previous trading day. The company announced the previous day via a regulatory filing that it had been selected for the “2026 First Round of Newly Funded Projects under the Inter-Ministerial Advanced Medical Device R&D Program,” organized by the Inter-Ministerial Medical Device R&D Project Group. GenQrix has signed an agreement to serve as a joint R&D partner for the project titled “Development of a Next-Generation Digital PCR Integrated Platform for Early Screening of Major Cancers.” The project period runs from April 1, 2026, to December 31, 2032, with a total budget of 29,383,740,000 won.
Amid a continued trend of net redemptions—where redemptions exceed new issuances—in the corporate bond market, Shinhan Investment Securities and GS Entec are set to conduct bookbuilding this week for …
I’ll try just about anything and report back to you. I’m interested in not only new products but also products making a comeback. I avoid simple reviews. I’ll also explain why a product is popular and…
SK Group has announced plans to invest an unprecedented amount of funds—totaling approximately 1,000 trillion won in total project costs alone—to develop South Korea into “Asia’s largest AI infrastruc…
